Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 102 articles:
HTML format
Text format



Single Articles


    March 2018
  1. TANDON P, Bishay K, Fisher S, Yelle D, et al
    Comparison of Clinical Outcomes Between Variceal and Non-Variceal Gastrointestinal Bleeding in Patients with Cirrhosis.
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14147.
    PubMed     Text format     Abstract available


    February 2018
  2. KIM TH, Ku DH, Um SH, Lee HA, et al
    How can we improve the performance of MELDNa score in patients with HBV-related decompensated liver cirrhosis commencing antiviral treatment?
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128.
    PubMed     Text format     Abstract available


  3. WIGG AJ, Chin JK, Muller KR, Ramachandran J, et al
    A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14127.
    PubMed     Text format     Abstract available


  4. DOI H, Hayashi E, Arai J, Tojo M, et al
    Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14123.
    PubMed     Text format     Abstract available


    January 2018
  5. KAO JH, Yu ML, Chen CY, Peng CY, et al
    Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
    J Gastroenterol Hepatol. 2018 Jan 18. doi: 10.1111/jgh.14096.
    PubMed     Text format     Abstract available


  6. FANG X, Liu LW, Dong J, Zhang J, et al
    A study about immunomodulatory effect and efficacy and prognosis of hUCMSCs in patients with CHB-induced decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jan 2. doi: 10.1111/jgh.14081.
    PubMed     Text format     Abstract available


    December 2017
  7. ATSUKAWA M, Tsubota A, Kato K, Abe H, et al
    Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14047.
    PubMed     Text format     Abstract available


    November 2017
  8. ISHIGAMI M, Hayashi K, Honda T, Kuzuya T, et al
    Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data.
    J Gastroenterol Hepatol. 2017;32:1879-1886.
    PubMed     Text format     Abstract available


    October 2017
  9. OTANI I, Oka S, Tanaka S, Tsuboi A, et al
    Clinical significance of small-bowel villous edema in patients with liver cirrhosis-a capsule endoscopy study.
    J Gastroenterol Hepatol. 2017 Oct 10. doi: 10.1111/jgh.14016.
    PubMed     Text format     Abstract available


    September 2017
  10. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
    Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
    J Gastroenterol Hepatol. 2017 Sep 15. doi: 10.1111/jgh.13989.
    PubMed     Text format     Abstract available


  11. SEO YS, Park SY, Kim MY, Kim SG, et al
    Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites.
    J Gastroenterol Hepatol. 2017 Sep 14. doi: 10.1111/jgh.13983.
    PubMed     Text format     Abstract available


  12. ZHANG B, Zhang CG, Ji LH, Zhao G, et al
    Estrogen receptor beta selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
    J Gastroenterol Hepatol. 2017 Sep 7. doi: 10.1111/jgh.13976.
    PubMed     Text format     Abstract available


    August 2017
  13. CHIRAPONGSATHORN S, Bunraksa W, Chaiprasert A, Punpanich D, et al
    Adding C-reactive protein and procalcitonin to the MELD score improves mortality prediction in patients with complications of cirrhosis.
    J Gastroenterol Hepatol. 2017 Aug 25. doi: 10.1111/jgh.13928.
    PubMed     Text format     Abstract available


  14. AMPUERO J, Montoliu C, Simon-Talero M, Aguilera V, et al
    Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
    J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13917.
    PubMed     Text format     Abstract available


    July 2017
  15. ELNEGOULY M, Umgelter K, Safi W, Hapfelmeier A, et al
    Elevated Cardiac Troponin T in Cirrhotic Patients with Emergency Care Admissions is Associated with Mortality.
    J Gastroenterol Hepatol. 2017 Jul 20. doi: 10.1111/jgh.13902.
    PubMed     Text format     Abstract available


  16. KIMER N, Pedersen JS, Tavenier J, Christensen JE, et al
    Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial.
    J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1111/jgh.13852.
    PubMed     Text format     Abstract available


    June 2017
  17. KIM BS, Seo YS, Kim YS, Lee CH, et al
    Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
    J Gastroenterol Hepatol. 2017 Jun 30. doi: 10.1111/jgh.13854.
    PubMed     Text format     Abstract available


  18. BERTRAIS S, Boursier J, Ducancelle A, Oberti F, et al
    Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
    J Gastroenterol Hepatol. 2017;32:1240-1249.
    PubMed     Text format     Abstract available


  19. CHAN HL, Tsang OT, Hui YT, Fung J, et al
    Real-life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong.
    J Gastroenterol Hepatol. 2017;32:1230-1233.
    PubMed     Text format     Abstract available


    May 2017
  20. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    PubMed     Text format     Abstract available


  21. JUN DW, Kim SG, Park SH, Jin SY, et al
    External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.
    J Gastroenterol Hepatol. 2017;32:1094-1099.
    PubMed     Text format     Abstract available


  22. PARKER R, Hodson J, Rowe IAC
    Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis.
    J Gastroenterol Hepatol. 2017;32:950-956.
    PubMed     Text format     Abstract available


    April 2017
  23. ITO K, Murotani K, Nakade Y, Inoue T, et al
    Serum WFA+ -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
    J Gastroenterol Hepatol. 2017 Apr 12. doi: 10.1111/jgh.13802.
    PubMed     Text format     Abstract available


    March 2017
  24. HSIEH YC, Lee KC, Chen PH, Su CW, et al
    Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding.
    J Gastroenterol Hepatol. 2017 Mar 8. doi: 10.1111/jgh.13777.
    PubMed     Text format     Abstract available


  25. TADA T, Kumada T, Toyoda H, Kiriyama S, et al
    Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.
    J Gastroenterol Hepatol. 2017;32:687-694.
    PubMed     Text format     Abstract available


  26. XU Q, Sheng L, Bao H, Chen X, et al
    Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis.
    J Gastroenterol Hepatol. 2017;32:639-644.
    PubMed     Text format     Abstract available


  27. LIU Z, Wei X, Chen T, Huang C, et al
    Characterization of fibrosis changes in chronic hepatitis C patients after virological cure: A systematic review with meta-analysis.
    J Gastroenterol Hepatol. 2017;32:548-557.
    PubMed     Text format     Abstract available


    February 2017
  28. JEON SR, Byeon JS, Jang HJ, Park SJ, et al
    Clinical outcome after enteroscopy for small bowel angioectasia bleeding: A Korean Associateion for the Study of Intestinal Disease (KASID) multiceter study.
    J Gastroenterol Hepatol. 2017;32:388-394.
    PubMed     Text format     Abstract available


  29. SOOD A, Khurana MS, Mahajan R, Midha V, et al
    Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2017;32:446-450.
    PubMed     Text format     Abstract available


    January 2017
  30. SEKI A, Ikeda F, Miyatake H, Takaguchi K, et al
    Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
    J Gastroenterol Hepatol. 2017 Jan 23. doi: 10.1111/jgh.13746.
    PubMed     Text format     Abstract available


  31. LEE SJ, Kim SU, Kim MD, Kim YH, et al
    Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13729.
    PubMed     Text format     Abstract available


  32. WANG Y, Huang W, Li R, Yun Z, et al
    Systematic Quantitation of Histologic Patterns Shows Accuracy in Reflecting Cirrhotic Remodeling.
    J Gastroenterol Hepatol. 2017 Jan 9. doi: 10.1111/jgh.13722.
    PubMed     Text format     Abstract available


  33. REY S, Quintavalle C, Burmeister K, Calabrese D, et al
    LIVER DAMAGE AND SENESCENCE INCREASES IN PATIENTS DEVELOPING HEPATOCELLULAR CARCINOMA.
    J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13717.
    PubMed     Text format     Abstract available


    December 2016
  34. BEKKI Y, Yoshizumi T, Shimoda S, Itoh S, et al
    Hepatic stellate cells secrete WFA+ -M2BP; its role in biological interactions with Kupffer cells.
    J Gastroenterol Hepatol. 2016 Dec 22. doi: 10.1111/jgh.13708.
    PubMed     Text format     Abstract available


  35. CHETCUTI ZAMMIT S, Chircop A, Cortis K, Pullicino E, et al
    Hepatobiliary and Pancreatic: Congenital intrahepatic portosystemic venous shunting: A great mimicker of liver cirrhosis.
    J Gastroenterol Hepatol. 2016;31:1917.
    PubMed     Text format    


    November 2016
  36. LEE YR, Park SY, Kim SU, Jang SY, et al
    Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
    J Gastroenterol Hepatol. 2016 Nov 10. doi: 10.1111/jgh.13644.
    PubMed     Text format     Abstract available


  37. BUSK TM, Moller S, Pedersen EB, Gerbes A, et al
    Aquaporin-2 Excretion in Hospitalized Patients with Cirrhosis: Relation to Development of Renal Insufficiency and Mortality.
    J Gastroenterol Hepatol. 2016 Nov 7. doi: 10.1111/jgh.13641.
    PubMed     Text format     Abstract available


    October 2016
  38. AHN JM, Kim CH, Um SH, Kim KM, et al
    A validation Study Associating Glutaminase Promoter Variations with Hepatic Encephalopathy in East Asian Populations.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13618.
    PubMed     Text format     Abstract available


    August 2016
  39. MORIO K, Imamura M, Kawakami Y, Morio R, et al
    Real-World Efficacy and Safety of Daclatasvir and Asunaprevir Therapy for Hepatitis C Virus-Infected Cirrhosis Patients.
    J Gastroenterol Hepatol. 2016 Aug 11. doi: 10.1111/jgh.13511.
    PubMed     Text format     Abstract available


    July 2016
  40. PARK TY, Lee SK, Nam K, Oh D, et al
    Spontaneous hemobilia after liver transplantation: frequency, risk factors, and outcome of endoscopic management.
    J Gastroenterol Hepatol. 2016 Jul 23. doi: 10.1111/jgh.13497.
    PubMed     Text format     Abstract available


  41. HURRY PK, Poulsen JH, Bendtsen F, Moller S, et al
    Neutrophil gelatinase associated lipocalin and Cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.
    J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13492.
    PubMed     Text format     Abstract available


  42. LEBRETON A, Sinegre T, Pereira B, Lamblin G, et al
    Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 Jul 15. doi: 10.1111/jgh.13493.
    PubMed     Text format     Abstract available


    June 2016
  43. LIANG XE, Zhong C, Huang L, Yang S, et al
    Stepwise Application of Transient Elastography and Routine Biomarkers Optimizes Hepatitis B Cirrhosis Detection.
    J Gastroenterol Hepatol. 2016 Jun 26. doi: 10.1111/jgh.13475.
    PubMed     Text format     Abstract available


    May 2016
  44. CHOLONGITAS E, Ioannidou M, Goulis I, Chalevas P, et al
    Comparison of Creatinine and Cystatin Formulae with 51 Chromium-Edta Glomerular Filtration Rate in Patients With Decompensated Cirrhosis.
    J Gastroenterol Hepatol. 2016 May 13. doi: 10.1111/jgh.13446.
    PubMed     Text format     Abstract available


  45. PATERNOSTRO R, Reiberger T, Mandorfer M, Schwarzer R, et al
    Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13439.
    PubMed     Text format     Abstract available


  46. KUTTING F, Schubert J, Franklin J, Bowe A, et al
    Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
    J Gastroenterol Hepatol. 2016 May 3. doi: 10.1111/jgh.13421.
    PubMed     Text format     Abstract available


    April 2016
  47. K YADAV S, Goel A, A Saraswat V, A Thomas M, et al
    Evaluation of Cognitivity, Proinflammatory Cytokines, and Brain MRI in Minimal Hepatic Encephalopathy induced by Cirrhosis and EHPVO.
    J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13427.
    PubMed     Text format     Abstract available


  48. CHIEN J, Liu J, Lee MH, Jen CL, et al
    Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis.
    J Gastroenterol Hepatol. 2016 Apr 26. doi: 10.1111/jgh.13422.
    PubMed     Text format     Abstract available


  49. TARDELLI M, Moreno-Viedma V, Zeyda M, Itariu BK, et al
    Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state.
    J Gastroenterol Hepatol. 2016 Apr 15. doi: 10.1111/jgh.13415.
    PubMed     Text format     Abstract available


  50. SHEPTULINA A, Shirokova E, Nekrasova T, Blum H, et al
    Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    J Gastroenterol Hepatol. 2016 Apr 5. doi: 10.1111/jgh.13407.
    PubMed     Text format     Abstract available


    March 2016
  51. KAO JH, Tung SY, Lee Y, Thongsawat S, et al
    Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
    J Gastroenterol Hepatol. 2016 Mar 19. doi: 10.1111/jgh.13374.
    PubMed     Text format     Abstract available


    February 2016
  52. FRIEDRICH K, Smit M, Wannhoff A, Rupp C, et al
    Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13319.
    PubMed     Text format     Abstract available


  53. LIU H, Liu J, Zhang Y, Liao J, et al
    Contrast-enhanced ultrasound and CT perfusion imaging of a liver fibrosis-early cirrhosis in dogs.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13320.
    PubMed     Text format     Abstract available


  54. PELUCCHI S, Galimberti S, Greni F, Rametta R, et al
    Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis.
    J Gastroenterol Hepatol. 2016 Feb 11. doi: 10.1111/jgh.13315.
    PubMed     Text format     Abstract available


  55. HALABI SA, Sawas T, Sadat B, Jandali A, et al
    Early TIPS Versus Endoscopic Therapy for Secondary Prophylaxis After Management of Acute Esophageal Variceal Bleeding in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
    J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13303.
    PubMed     Text format     Abstract available


    December 2015
  56. SINGH J, Sharma BC, Maharshi S, Puri V, et al
    Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    J Gastroenterol Hepatol. 2015 Dec 30. doi: 10.1111/jgh.13283.
    PubMed     Text format     Abstract available


  57. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
    Performance of magnetic resonance elastography in primary sclerosing cholangitis.
    J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
    PubMed     Text format     Abstract available


  58. QIN B, Wei T, Wang L, Ma N, et al
    Decreased expression of TIPE2 contributes to the hyper-reactivity of monocyte to TLR ligands in primary biliary cirrhosis.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13251.
    PubMed     Text format     Abstract available


  59. GAETANO JN, Micic D, Aronsohn A, Reddy G, et al
    The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13255.
    PubMed     Text format     Abstract available


  60. VAN DER MEER AJ, Maan R, Veldt BJ, Feld JJ, et al
    Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13252.
    PubMed     Text format     Abstract available


    November 2015
  61. MAIWALL R, Kumar S, Sharma MK, Wani Z, et al
    Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13243.
    PubMed     Text format     Abstract available


  62. GASSIEP I, Clark PJ, McManus DP, Looke DL, et al
    Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic schistosoma mansoni infection and post- praziquantel therapy.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13239.
    PubMed     Text format    


  63. NAGAOKI Y, Aikata H, Nakano N, Shinohara F, et al
    Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
    J Gastroenterol Hepatol. 2015 Nov 19. doi: 10.1111/jgh.13236.
    PubMed     Text format     Abstract available


  64. KIM Y, Lee EJ, Jang HK, Kim CH, et al
    Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
    PubMed     Text format     Abstract available


    October 2015
  65. BALDUCCI G, Sterpetti AV, Ventura M
    A short history of portal hypertension and of its management.
    J Gastroenterol Hepatol. 2015 Oct 29. doi: 10.1111/jgh.13200.
    PubMed     Text format     Abstract available


  66. ZHANG F, Duan X, Zhang M, Li Z, et al
    Influence of CYP2D6 and beta2-adrenergic receptor gene polymorphisms on the hemodynamic response to propranolol in Chinese Han patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13198.
    PubMed     Text format     Abstract available


  67. WANG D, Wang Q, Yin J, Dong R, et al
    Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
    PubMed     Text format     Abstract available


    September 2015
  68. CARIAS S, Castellanos AL, Vilchez V, Nair R, et al
    Non-alcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    J Gastroenterol Hepatol. 2015 Sep 23. doi: 10.1111/jgh.13166.
    PubMed     Text format     Abstract available


  69. LIN SY, Wang YY, Chuang YH, Chen CJ, et al
    Skeletal muscle proteolysis is associated with sympathetic activation and TNF-alpha-ubiquitin-proteasome pathway in liver cirrhotic rats.
    J Gastroenterol Hepatol. 2015 Sep 23. doi: 10.1111/jgh.13159.
    PubMed     Text format     Abstract available


    August 2015
  70. MORGAN ML, Sigala B, Soeda J, Cordero P, et al
    Acetylcholine induces fibrogenic effects via M2/M3 ACh receptors in NASH and in primary human hepatic stellate cells.
    J Gastroenterol Hepatol. 2015 Aug 13. doi: 10.1111/jgh.13085.
    PubMed     Text format     Abstract available


  71. BAO Q, Wang B, Yu L, Weng H, et al
    A modified prognostic score for critically ill patients with cirrhosis: an observational study.
    J Gastroenterol Hepatol. 2015 Aug 7. doi: 10.1111/jgh.13076.
    PubMed     Text format     Abstract available


  72. TU T, Calabro SR, Lee A, Maczurek AE, et al
    Hepatocytes in liver injury: victim, bystander, or accomplice in progressive fibrosis?
    J Gastroenterol Hepatol. 2015 Aug 4. doi: 10.1111/jgh.13065.
    PubMed     Text format     Abstract available


    July 2015
  73. SANTOS LA, Lima TB, Augusti L, de Campos Franzoni L, et al
    Handgrip strength as a predictor of bone mineral density in cirrhotic outpatients.
    J Gastroenterol Hepatol. 2015 Jul 25. doi: 10.1111/jgh.13062.
    PubMed     Text format     Abstract available


  74. ZHANG CX, Xu JM, Li JB, Kong DR, et al
    Predict esophageal varices via routine trans-abdominal ultrasound: A design of classification analysis model.
    J Gastroenterol Hepatol. 2015 Jul 21. doi: 10.1111/jgh.13045.
    PubMed     Text format     Abstract available


  75. SEO JH, Song MJ
    Complete Remission after Hepatic Arterial Infusion Chemotherapy for advanced Hepatocellular carcinoma with decompensated cirrhosis.
    J Gastroenterol Hepatol. 2015 Jul 15. doi: 10.1111/jgh.13033.
    PubMed     Text format    


  76. KUMAR S
    Hepatology: De novo primary sclerosing cholangitis post liver transplantation.
    J Gastroenterol Hepatol. 2015;30:1114.
    PubMed     Text format    


    June 2015
  77. SHIN SK, Kim JH, Park H, Kwon OS, et al
    Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment.
    J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13020.
    PubMed     Text format     Abstract available


  78. OGAWA E, Furusyo N, Kajiwara E, Nomura H, et al
    Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
    J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13016.
    PubMed     Text format     Abstract available


    May 2015
  79. MAHARSHI S, Sharma BC, Srivastava S
    Malnutrition in Cirrhosis Increases Morbidity and Mortality.
    J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12999.
    PubMed     Text format     Abstract available


  80. LIN JS, Zhou L, Sagayaraj A, Jumat NH, et al
    Hepatic differentiation of Human Amniotic Epithelial cells and in vivo therapeutic effect on animal model of cirrhosis.
    J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12991.
    PubMed     Text format     Abstract available


  81. YOU SC, Kim KJ, Kim SU, Kim BK, et al
    Hepatic fibrosis assessed using transient elastography is independently associated with coronary artery calcification.
    J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12992.
    PubMed     Text format     Abstract available


  82. MARUYAMA H, Kondo T, Kiyono S, Sekimoto T, et al
    Relationship and interaction between serum sodium concentration and portal hemodynamics in patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 May 13. doi: 10.1111/jgh.13006.
    PubMed     Text format     Abstract available


  83. BUCSICS T, Mandorfer M, Schwabl P, Bota S, et al
    Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: a retrospective cohort study.
    J Gastroenterol Hepatol. 2015 May 13. doi: 10.1111/jgh.13002.
    PubMed     Text format     Abstract available


    April 2015
  84. KHOKHAR N, Qureshi MO, Ahmad S, Ahmad A, et al
    Comparison of once a day rifaximin to twice a day dosage in prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2015 Apr 13. doi: 10.1111/jgh.12970.
    PubMed     Text format     Abstract available


  85. JIA J, Hou J, Ding H, Chen G, et al
    Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2015;30:756-62.
    PubMed     Text format     Abstract available


  86. CAVIGLIA GP, Sciacca C, Abate ML, Olivero A, et al
    Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.
    J Gastroenterol Hepatol. 2015;30:742-7.
    PubMed     Text format     Abstract available


  87. SHI Y, Zheng MH, Yang Y, Wei W, et al
    Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation.
    J Gastroenterol Hepatol. 2015;30:712-8.
    PubMed     Text format     Abstract available


    March 2015
  88. KEMP W, Levy M, Weltman M, Lubel J, et al
    Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.
    J Gastroenterol Hepatol. 2015;30:453-62.
    PubMed     Text format     Abstract available


  89. WONG GL, Chan HL, Yu Z, Wong CK, et al
    Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2015;30:582-90.
    PubMed     Text format     Abstract available


  90. AGRAWAL S, Duseja A, Gupta T, Dhiman RK, et al
    Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure.
    J Gastroenterol Hepatol. 2015;30:575-81.
    PubMed     Text format     Abstract available


  91. DING H, Ma JJ, Wang WP, Zeng WJ, et al
    Assessment of liver fibrosis: the relationship between point shear wave elastography and quantitative histological analysis.
    J Gastroenterol Hepatol. 2015;30:553-8.
    PubMed     Text format     Abstract available


  92. YANG Y, Zhao Z, Liu Y, Kang X, et al
    Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling.
    J Gastroenterol Hepatol. 2015;30:609-18.
    PubMed     Text format     Abstract available


    February 2015
  93. MAAN R, van der Meer AJ, Hansen BE, Feld JJ, et al
    Risk of infections during interferon-based treatment in patients with chronic HCV infection and advanced hepatic fibrosis.
    J Gastroenterol Hepatol. 2015 Feb 13. doi: 10.1111/jgh.12929.
    PubMed     Text format     Abstract available


  94. CENGIZ M, Ozenirler S, Elbeg S
    The role of serum toll-like receptors 2 and 4 in nonalcoholic steatohepatitis and liver fibrosis.
    J Gastroenterol Hepatol. 2015 Feb 13. doi: 10.1111/jgh.12924.
    PubMed     Text format     Abstract available


  95. LIN MT, Chang KC, Chou YP, Tseng PL, et al
    The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area.
    J Gastroenterol Hepatol. 2015;30:345-51.
    PubMed     Text format     Abstract available


  96. SINCLAIR M, Grossmann M, Gow PJ, Angus PW, et al
    Testosterone in men with advanced liver disease: abnormalities and implications.
    J Gastroenterol Hepatol. 2015;30:244-51.
    PubMed     Text format     Abstract available


    January 2015
  97. DONG R, Zheng S
    Interleukin-8: A critical chemokine in biliary atresia.
    J Gastroenterol Hepatol. 2015 Jan 22. doi: 10.1111/jgh.12900.
    PubMed     Text format     Abstract available


  98. WANG CC, Tseng TC, Kao JH
    Hepatitis B virus infection and metabolic syndrome: fact or fiction?
    J Gastroenterol Hepatol. 2015;30:14-20.
    PubMed     Text format     Abstract available


    December 2014
  99. QU K, Yan Z, Wu Y, Chen Y, et al
    Transarterial chemoembolization aggravated peritumoral fibrosis via HIF-1alpha dependent pathway in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2014 Dec 30. doi: 10.1111/jgh.12873.
    PubMed     Text format     Abstract available


    November 2014
  100. HOWELL J, Van Gemert C, Lemoine M, Thursz M, et al
    Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.
    J Gastroenterol Hepatol. 2014;29:1854-66.
    PubMed     Text format     Abstract available


    October 2014
  101. KIM SH, Keum B, Kim ES, Jeen YT, et al
    Hepatobiliary and Pancreatic: Caput Medusae.
    J Gastroenterol Hepatol. 2014 Oct 10. doi: 10.1111/jgh.12802.
    PubMed     Text format    


    August 2014
  102. SOBBE A, Bridle KR, Jaskowski L, de Guzman CE, et al
    Inconsistent hepatic antifibrotic effects with the iron chelator Deferasirox.
    J Gastroenterol Hepatol. 2014 Aug 28. doi: 10.1111/jgh.12720.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: